共 50 条
- [31] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT StudyBLOOD, 2018, 132Kawashima, NaomiIshikawa, YuichiAtsuta, YoshikoSugiura, IsamuSawa, MasashiDobashi, NobuakiYokoyama, HisayukiDoki, NorikoTomita, AkihiroKiguchi, ToruKoh, ShiroKanamori, HeiwaIriyama, NoriyoshiKohno, AkioMoriuchi, YukiyoshiAsada, NoboruHirano, DaikiTogitani, KazutoSakura, ToruHagihara, MakiTomikawa, TatsukiYokoyama, YasuhisaAsou, NorioOhtake, ShigekiMatsumura, ItaruMiyazaki, YasushiNaoe, TomokiKiyoi, Hitoshi
- [32] Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)-An International StudyBLOOD, 2011, 118 (21) : 1080 - 1081Wetzler, MeirKohlschmidt, JessicaMrozek, KrzysztofDombret, HerveDoehner, HartmutPilorge, SylvainKrug, UtzLarson, Richard A.Marcucci, GuidoHiddemann, WolfgangBuchner, ThomasBloomfield, Clara D.
- [33] RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)BLOOD, 2018, 132Kim, TaehyungMoon, Joon HoAhn, Jae-SookTyndel, Marc S.Lee, Seung-ShinAhn, Seo-YeonJung, Sung-HoonYang, Deok-HwanLee, Je-JungChoi, SeunghyunLee, Ja-yeonLee, YoojinSohn, Sang KyunZhang, ZhaoleiKim, Hyeoung-JoonKim, Dennis Dong Hwan
- [34] JAK2 V617F mutation screening in patients with chronic myeloproliferative disorders and core binding factor acute myeloid leukemias (CBF-AML)HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 393 - 393Markova, J.Michkova, P.Star, J.Schwarz, J.
- [35] Prognostic significance of age and cytogenetics in elderly patients with acute myeloid leukemia.BLOOD, 1997, 90 (10) : 3798 - 3798Usui, NDobashi, NKato, AMaki, NAsai, OKobayashi, TTajima, NKuraishi, Y
- [36] Outcome prediction in adult core binding factor (CBF) acute myeloid leukemia (AML) with gene expression profiling: A Cancer and Leukemia Group B (CALGB) studyJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Paschka, P.Radmacher, M. D.Marcucci, G.Ruppert, A. S.Vukosavljevic, T.Whitman, S. P.Mrozek, K.Liu, C.Larson, R. A.Bloomfield, C. D.
- [37] Additional Prognostic Impact of Specific Sites of Extramedullary Leukemia in Pediatric AML with MLL-Rearrangements but Not in Core-Binding Factor (CBF) AMLBLOOD, 2012, 120 (21)Creutzig, UrsulaZimmermann, MartinDworzak, MichaelBourquin, Jean-Pierrevon Neuhoff, ChristineSander, AnnetteStary, JanReinhardt, Dirk
- [38] Single-Agent Dasatinib Does Not Prevent Hematological Relapse in Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) in First Complete Remission, but Persistent or Re-Appearing Molecular Minimal Residual Disease-Results of the DASA-CBF Trial From the French AML IntergroupBLOOD, 2011, 118 (21) : 1119 - 1119Boissel, NicolasJourdan, EricPigneux, ArnaudBlanchet, OdileRenneville, AlineRecher, ChristianRaffoux, EmmanuelCornillet-Lefebvre, PascaleCayuela, Jean-MichelDelaunay, JacquesDelabesse, EricBulabois, Claude-EricBerthon, CelinePautas, CecileVey, NorbertLioure, BrunoThomas, XavierKammoun, LeilaRandriamalala, EdouardFegueux, NathalieLecerf, ThibaudBene, Marie-ChristinePreudhomme, ClaudeMohamed, HeshamDombret, HerveIfrah, Norbert
- [39] DASATINIB (DAS) IN COMBINATION WITH CHEMOTHERAPY AND AS MAINTENANCE IN CORE-BINDING FACTOR (CBF) ACUTE MYELOID LEUKEMIA (AML): A PHASE IB/IIA STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)HAEMATOLOGICA, 2015, 100 : 194 - 195Paschka, P.Schlenk, R. F.Weber, D.Fiedler, W.Luebbert, M.Theobald, M.Greil, R.Horst, H. -A.Krauter, J.Salih, H. R.Heil, G.Martens, U.Kuendgen, A.Brossart, P.Heuser, M.Gaidzik, V. I.Thol, F.Goehring, G.Ganser, A.Doehner, K.Doehner, H.
- [40] Overweight is An Independent Adverse Prognostic Factor in Acute Myeloid Leukemia (AML) in Younger PatientsANNALS OF HEMATOLOGY, 2015, 94 : S76 - S77Capovilla, S.Herold, T.Sauerland, C.Berdel, W.Woermann, B.Buechner, T.Hiddemann, W.Fiegl, M.